Search research articles
Contact Us
Filters
Showing results (211-220 of 318) with videos related to
Page
of 32
Sort By:
Blood
|
May 9, 2008
Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study
Bertrand Godeau, Raphael Porcher, Olivier Fain, et al.
European Journal of Haematology
|
September 1, 2022
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma
Adrien Daniel, David Ghez, Camille Ravaiau, et al.
The New England Journal of Medicine
|
April 7, 2021
Sutimlimab in Cold Agglutinin Disease
Alexander Röth, Wilma Barcellini, Shirley D'Sa, et al.
Arthritis and Rheumatism
|
July 9, 2003
Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis
Fotini B Karassa, Marc Bijl, Kevin A Davies, et al.
American Journal of Hematology
|
October 30, 2020
High dose romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopenia
Mathilde Roumier, Sébastien Le Burel, Sylvain Audia, et al.
British Journal of Haematology
|
March 18, 2022
Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) network
Guillaume Moulis, Nichola Cooper, Waleed Ghanima, et al.
American Journal of Hematology
|
November 15, 2021
Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study
Guillaume Moulis, Johanne Germain, Manuela Rueter, et al.
ACS Applied Materials & Interfaces
|
October 8, 2019
Targeted Surface Doping with Reversible Local Environment Improves Oxygen Stability at the Electrochemical Interfaces of Nickel-Rich Cathode Materials
James D Steiner, Hao Cheng, Julia Walsh, et al.
Blood Advances
|
September 30, 2024
Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies
Margaux Soulard, Lionel Galicier, Nizar Mahlaoui, et al.
Rheumatology (Oxford, England)
|
May 15, 2018
Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists
Zelie Guitton, Louis Terriou, Jean-Christophe Lega, et al.
Page
of 32
Search research articles
Search
Showing results (211-220 of 318) with videos related to
Sort By:
Page
of 32
Blood
|
May 9, 2008
Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study
Bertrand Godeau, Raphael Porcher, Olivier Fain, et al.
European Journal of Haematology
|
September 1, 2022
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma
Adrien Daniel, David Ghez, Camille Ravaiau, et al.
The New England Journal of Medicine
|
April 7, 2021
Sutimlimab in Cold Agglutinin Disease
Alexander Röth, Wilma Barcellini, Shirley D'Sa, et al.
Arthritis and Rheumatism
|
July 9, 2003
Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis
Fotini B Karassa, Marc Bijl, Kevin A Davies, et al.
American Journal of Hematology
|
October 30, 2020
High dose romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopenia
Mathilde Roumier, Sébastien Le Burel, Sylvain Audia, et al.
British Journal of Haematology
|
March 18, 2022
Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) network
Guillaume Moulis, Nichola Cooper, Waleed Ghanima, et al.
American Journal of Hematology
|
November 15, 2021
Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study
Guillaume Moulis, Johanne Germain, Manuela Rueter, et al.
ACS Applied Materials & Interfaces
|
October 8, 2019
Targeted Surface Doping with Reversible Local Environment Improves Oxygen Stability at the Electrochemical Interfaces of Nickel-Rich Cathode Materials
James D Steiner, Hao Cheng, Julia Walsh, et al.
Blood Advances
|
September 30, 2024
Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies
Margaux Soulard, Lionel Galicier, Nizar Mahlaoui, et al.
Rheumatology (Oxford, England)
|
May 15, 2018
Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists
Zelie Guitton, Louis Terriou, Jean-Christophe Lega, et al.
Page
of 32